179 related articles for article (PubMed ID: 28230312)
1. Five-year cost-effectiveness of the Patient Empowerment Programme (PEP) for type 2 diabetes mellitus in primary care.
Lian J; McGhee SM; So C; Chau J; Wong CKH; Wong WCW; Lam CLK
Diabetes Obes Metab; 2017 Sep; 19(9):1312-1316. PubMed ID: 28230312
[TBL] [Abstract][Full Text] [Related]
2. Long-term cost-effectiveness of a Patient Empowerment Programme for type 2 diabetes mellitus in primary care.
Lian J; McGhee SM; So C; Chau J; Wong CKH; Wong WCW; Lam CLK
Diabetes Obes Metab; 2019 Jan; 21(1):73-83. PubMed ID: 30058268
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with Type 2 diabetes: results from a randomized controlled trial.
Simpson SH; Lier DA; Majumdar SR; Tsuyuki RT; Lewanczuk RZ; Spooner R; Johnson JA
Diabet Med; 2015 Jul; 32(7):899-906. PubMed ID: 25594919
[TBL] [Abstract][Full Text] [Related]
4. Patient Empowerment Programme in primary care reduced all-cause mortality and cardiovascular diseases in patients with type 2 diabetes mellitus: a population-based propensity-matched cohort study.
Wong CK; Wong WC; Wan YF; Chan AK; Chung KL; Chan FW; Lam CL
Diabetes Obes Metab; 2015 Feb; 17(2):128-35. PubMed ID: 25251664
[TBL] [Abstract][Full Text] [Related]
5. Five-Year Cost-effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM).
Jiao FF; Fung CSC; Wan EYF; Chan AKC; McGhee SM; Kwok RLP; Lam CLK
Diabetes Care; 2018 Feb; 41(2):250-257. PubMed ID: 29246949
[TBL] [Abstract][Full Text] [Related]
6. Early specialist care for diabetes: who benefits most? A propensity score-matched cohort study.
Booth GL; Shah BR; Austin PC; Hux JE; Luo J; Lok CE
Diabet Med; 2016 Jan; 33(1):111-8. PubMed ID: 25981183
[TBL] [Abstract][Full Text] [Related]
7. Macrovascular and microvascular disease in obese patients with type 2 diabetes attending structured diabetes education program: a population-based propensity-matched cohort analysis of Patient Empowerment Programme (PEP).
Wong CK; Wong WC; Wan EY; Chan AK; Chan FW; Lam CL
Endocrine; 2016 Aug; 53(2):412-22. PubMed ID: 26785847
[TBL] [Abstract][Full Text] [Related]
8. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
Yu J; Shah BM; Ip EJ; Chan J
J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
[TBL] [Abstract][Full Text] [Related]
9. Five-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on Diabetes-Related Complications and Health Service Uses-A Population-Based and Propensity-Matched Cohort Study.
Wan EYF; Fung CSC; Jiao FF; Yu EYT; Chin WY; Fong DYT; Wong CKH; Chan AKC; Chan KHY; Kwok RLP; Lam CLK
Diabetes Care; 2018 Jan; 41(1):49-59. PubMed ID: 29138274
[TBL] [Abstract][Full Text] [Related]
10. Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer.
Holden SE; Jenkins-Jones S; Morgan CL; Schernthaner G; Currie CJ
Diabetes Obes Metab; 2015 Apr; 17(4):350-62. PubMed ID: 25399739
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial.
Tao L; Wilson EC; Wareham NJ; Sandbaek A; Rutten GE; Lauritzen T; Khunti K; Davies MJ; Borch-Johnsen K; Griffin SJ; Simmons RK
Diabet Med; 2015 Jul; 32(7):907-19. PubMed ID: 25661661
[TBL] [Abstract][Full Text] [Related]
12. Inpatient Glycemic Variability and Long-Term Mortality in Hospitalized Patients with Type 2 Diabetes.
Timmons JG; Cunningham SG; Sainsbury CA; Jones GC
J Diabetes Complications; 2017 Feb; 31(2):479-482. PubMed ID: 27343028
[TBL] [Abstract][Full Text] [Related]
13. Cost implications of the use of basal insulin glargine in people with early dysglycemia: the ORIGIN trial.
Lamy A; Tong W; Jung H; Gafni A; Singh K; Tyrwhitt J; Yusuf S; Gerstein HC;
J Diabetes Complications; 2014; 28(4):553-8. PubMed ID: 24684774
[TBL] [Abstract][Full Text] [Related]
14. Results of ACCORDIAN in ACCORD with lower blood pressure begetting lower mortality in patients with diabetes.
Laffin LJ; Bakris GL
Diabetes Obes Metab; 2018 Jun; 20(6):1335-1336. PubMed ID: 29424470
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of patient-reported outcomes data in structured diabetes education intervention: 2-year follow-up data of patient empowerment programme.
Wong CK; Lam CL; Wan EY; Chan AK; Pak CH; Chan FW; Wong WC
Endocrine; 2016 Nov; 54(2):422-432. PubMed ID: 27623970
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand.
Permsuwan U; Chaiyakunapruk N; Dilokthornsakul P; Thavorn K; Saokaew S
Appl Health Econ Health Policy; 2016 Jun; 14(3):281-92. PubMed ID: 26961276
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of the multidisciplinary risk assessment and management program for patients with diabetes mellitus (RAMP-DM): a population-based cohort study.
Jiao F; Fung CS; Wan YF; McGhee SM; Wong CK; Dai D; Kwok R; Lam CL
Cardiovasc Diabetol; 2015 Aug; 14():105. PubMed ID: 26268736
[TBL] [Abstract][Full Text] [Related]
18. Poststroke glycemic variability increased recurrent cardiovascular events in diabetic patients.
Yoon JE; Sunwoo JS; Kim JS; Roh H; Ahn MY; Woo HY; Lee KB
J Diabetes Complications; 2017 Feb; 31(2):390-394. PubMed ID: 27956053
[TBL] [Abstract][Full Text] [Related]
19. Fasting and post-prandial glucose and diabetic complication. A meta-analysis.
Monami M; Adalsteinsson JE; Desideri CM; Ragghianti B; Dicembrini I; Mannucci E
Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):591-8. PubMed ID: 23711419
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of metformin plus vildagliptin compared with metformin plus sulphonylurea for the treatment of patients with type 2 diabetes mellitus: a Portuguese healthcare system perspective.
Viriato D; Calado F; Gruenberger JB; Ong SH; Carvalho D; Silva-Nunes J; Johal S; Viana R
J Med Econ; 2014 Jul; 17(7):499-507. PubMed ID: 24708176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
